skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pertussis toxins, other antigens become likely targets for genetic engineering

Abstract

Genetically engineered pertussis vaccines have yet to be fully tested clinically. But early human, animal, and in vitro studies indicate effectiveness in reducing toxic effects due to Bordetella pertussis. The licensed pertussis vaccines consists of inactivated whole cells of the organism. Although highly effective, they have been associated with neurologic complications. While the evidence continues to mount that these complications are extremely rare, if they occur at all, it has affected the public's acceptance of pertussis immunization.

Authors:
Publication Date:
OSTI Identifier:
5556788
Resource Type:
Journal Article
Resource Relation:
Journal Name: JAMA, Journal of the American Medical Association; (United States); Journal Volume: 264:18
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; ANTIGENS; AMINO ACID SEQUENCE; TOXINS; GENETIC ENGINEERING; BACTERIA; IMMUNITY; MUTANTS; NERVOUS SYSTEM DISEASES; BIOTECHNOLOGY; DISEASES; MATERIALS; MICROORGANISMS; MOLECULAR STRUCTURE; TOXIC MATERIALS; 550400* - Genetics

Citation Formats

Marwick, C. Pertussis toxins, other antigens become likely targets for genetic engineering. United States: N. p., 1990. Web. doi:10.1001/jama.1990.03450180023004.
Marwick, C. Pertussis toxins, other antigens become likely targets for genetic engineering. United States. doi:10.1001/jama.1990.03450180023004.
Marwick, C. 1990. "Pertussis toxins, other antigens become likely targets for genetic engineering". United States. doi:10.1001/jama.1990.03450180023004.
@article{osti_5556788,
title = {Pertussis toxins, other antigens become likely targets for genetic engineering},
author = {Marwick, C.},
abstractNote = {Genetically engineered pertussis vaccines have yet to be fully tested clinically. But early human, animal, and in vitro studies indicate effectiveness in reducing toxic effects due to Bordetella pertussis. The licensed pertussis vaccines consists of inactivated whole cells of the organism. Although highly effective, they have been associated with neurologic complications. While the evidence continues to mount that these complications are extremely rare, if they occur at all, it has affected the public's acceptance of pertussis immunization.},
doi = {10.1001/jama.1990.03450180023004},
journal = {JAMA, Journal of the American Medical Association; (United States)},
number = ,
volume = 264:18,
place = {United States},
year = 1990,
month =
}
  • No abstract prepared.
  • This paper reports on Hungary's remarkable recent efforts to reform its politics and economy along increasingly Western lines. These reforms include broad changes in petroleum exploration and production. The country has an area approximately that of the state of Indiana and consists primarily of a flat plain with low foothills of the Carpathian Mountains in the north.
  • T cell proliferative responses to Mycobacterium leprae were measured by immunization of mice at the base of the tail with Ag and challenging lymphocytes from draining lymph nodes in culture with M. leprae. C57BL/10J and B10.BR mice were identified as low responder mice and the congenic strains B10.M, B10.Q, and B10.AKM as high responders whereas F1 (high x low) hybrid mice were found to be low responders. The cellular basis of low responsiveness did not appear to result from a defect in Ag-presenting cells or the activation of suppressor T cells by M. leprae. The influence of the environment inmore » which T cells developed on responsiveness to M. leprae was analyzed in chimeric mice prepared by irradiating F1(C57BL/10J x B10.M) mice and reconstituting with bone marrow from C57BL/10J, B10.M, or F1 donors. Six weeks later, chimeric mice were immunized with M. leprae, lymph node cells were subsequently prepared, and H-2 phenotyped and challenged in culture with M. leprae Ag. T cell proliferative responses were found to be low in all cases, similar to those observed using lymph node cells from F1 hybrid mice. These results suggested that high responder B10.M lymphocytes developing in the irradiated F1 mice became tolerized to antigenic determinants found on M. leprae. This implied cross-reactive epitopes existed between some mouse strains and M. leprae. Low responsiveness to M. leprae in low responder and F1 hybrid mice may result from tolerance to H-2-encoded Ag that show cross-reactivity with M. leprae.« less
  • The theta antigen of the mouse provides a cell surface marker for Thymus-derived lymphocytes. The allelic variants of this antigen, Thy 1.1 and Thy 1.2, are expressed by the Thy-1a and Thy-1b alleles. The strain distribution and genetic segregation data presented here show that reagents specific for the Thy-1.2 antigen of the mouse can be prepared by the absorption of heteroantisera raised in rats. It seems likely that the capacity of rats to produce specific anti-Thy-1.2 antibodies is associated with their possession of a self antigen indistinguishable from Thy-1.1. In any case, rat antisera now appear to be a readymore » source of reagents for the detection of at least one class of lymphocyte alloantigens in the mouse.« less
  • Human leukocyte antigen (HLA) gene polymorphism plays a critical role in protective immunity, disease susceptibility, autoimmunity, and drug hypersensitivity, yet the basis of how HLA polymorphism influences T cell receptor (TCR) recognition is unclear. We examined how a natural micropolymorphism in HLA-B44, an important and large HLA allelic family, affected antigen recognition. T cell-mediated immunity to an Epstein-Barr virus determinant (EENLLDFVRF) is enhanced when HLA-B*4405 was the presenting allotype compared with HLA-B*4402 or HLA-B*4403, each of which differ by just one amino acid. The micropolymorphism in these HLA-B44 allotypes altered the mode of binding and dynamics of the bound viralmore » epitope. The structure of the TCR-HLA-B*4405EENLLDFVRF complex revealed that peptide flexibility was a critical parameter in enabling preferential engagement with HLA-B*4405 in comparison to HLA-B*4402/03. Accordingly, major histocompatibility complex (MHC) polymorphism can alter the dynamics of the peptide-MHC landscape, resulting in fine-tuning of T cell responses between closely related allotypes.« less